Safety and immunogenicity of a novel 10-valent pneumococcal conjugate vaccine candidate in adults, toddlers, and infants in The Gambia-Results of a phase 1/2 randomized, double-blinded, controlled trial. (2020)

First Author: Clarke E


No abstract provided

Bibliographic Information

Digital Object Identifier:

PubMed Identifier: 31843266

Publication URI:

Type: Journal Article/Review

Volume: 38

Parent Publication: Vaccine

Issue: 2

ISSN: 0264-410X